AIDS: the virus, antivirals and vaccines
Weber, J.
British Journal of Hospital Medicine 37(2): 135-137; 140-141
1987
ISSN/ISBN: 0007-1064 PMID: 2950962 Document Number: 304057
The speed of research into the pathogenesis of AIDS is breathtaking, and it is now possible to review potential therapeutic approaches against the AIDS virus. This review concentrates upon antiviral drugs and vaccine development.
Document emailed within 1 workday
Related Documents
Parkman, P.D.; Hopps, H.E. 1988: Viral vaccines and antivirals: current use and future prospects Annual Review of Public Health 9: 203-221Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus Microbiology and Immunology 29(11): 1083-1087
Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus Microbiology and Immunology 29(11): 1083-1087
Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus Microbiology and Immunology 29(11): 1083-1087
Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus Microbiology and Immunology 29(11): 1083-1087
Cymerys, J.; Dzieciątkowski, T.; Golke, A.; Słońska, A.; Majewska, A.; Krzyżowska, M.; Bańbura, M.W. 2013: Primary cultures of murine neurons for studying herpes simplex virus 1 infection and its inhibition by antivirals Acta Virologica 57(3): 339-345
Clements, C.J.; Abdool-Karim, Q.; Chang, M.-L.; Nkowane, B.; Esparza, J. 2004: Breaking new ground--are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents? Vaccine 22(21-22): 2822-2826
Dane, D.S.; Dick, G.W.A.; Connolly, J.H.; Fisher, O.D.; McKeown, F.; Briggs, M.; Nelson, R.; Wilson, D. 1957: Vaccination Against Poliomyelitis with Live Virus Vaccines: 1. a Trial of TN Type Ii Vaccine. 2. a Trial of SM Type i Attenuated Poliomyelitis Virus Vaccine. 3. the Evaluation of TN and SM Virus Vaccines BMJ 1(5010): 59-74
Zarling, J.M.; Eichberg, J.W.; Moran, P.A.; McClure, J.; Sridhar, P.; Hu, S.L. 1987: Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins Journal of Immunology 139(4): 988-990
Van Wezel, A.L.; van Herwaarden, J.A.; van de Heuvel-de Rijk, E.W. 1979: Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines Developments in Biological Standardization 42: 65-69
Jones, L.; Tenorio, E.; Gorham, J.; Yilma, T. 1997: Protective vaccination of ferrets against canine distemper with recombinant pox virus vaccines expressing the H or F genes of rinderpest virus American Journal of Veterinary Research 58(6): 590-593
Bernstein, D.I.; Zahradnik, J.M.; DeAngelis, C.J.; Cherry, J.D. 1982: Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months Pediatrics 69(4): 404-408
Cherney, T.M.; Schultz, R.D. 1996: Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes American Journal of Veterinary Research 57(6): 812-818
Higashihara, M.; Igarashi, Y.; Saito, Y. 1976: Recombinant influenza-virus vaccines. IV. Segregation of antigenic and some biological properties of Influenza virus neuraminidase by recombination Kitasato Archives of Experimental Medicine 49(3): 81-91
Pinkerton, S.D.; Abramson, P.R. 1997: Condoms and the prevention of AIDS: improving and promoting condoms may be a more effective tactic than monogamy, drugs or vaccines in fighting AIDS and other sexually transmitted diseases American Scientist 85(4): 364-373
Pinkerton, S.D.; Abramson, P.R. 1997: Condoms and the prevention of AIDS: improving and promoting condoms may be a more effective tactic than monogamy, drugs or vaccines in fighting AIDS and other sexually transmitted diseases American Scientist 85(4): 364-373
Pinkerton, S.D.; Abramson, P.R. 1997: Condoms and the prevention of AIDS: improving and promoting condoms may be a more effective tactic than monogamy, drugs or vaccines in fighting AIDS and other sexually transmitted diseases American Scientist 85(4): 364-373
Pinkerton, S.D.; Abramson, P.R. 1997: Condoms and the prevention of AIDS: improving and promoting condoms may be a more effective tactic than monogamy, drugs or vaccines in fighting AIDS and other sexually transmitted diseases American Scientist 85(4): 364-373
Pinkerton, S.D.; Abramson, P.R. 1997: Condoms and the prevention of AIDS: improving and promoting condoms may be a more effective tactic than monogamy, drugs or vaccines in fighting AIDS and other sexually transmitted diseases American Scientist 85(4): 364-373
Pinkerton, S.D.; Abramson, P.R. 1997: Condoms and the prevention of AIDS: improving and promoting condoms may be a more effective tactic than monogamy, drugs or vaccines in fighting AIDS and other sexually transmitted diseases American Scientist 85(4): 364-373